Authors
Latest:
Strategic Transformation of a Global Medical Information ProgramThe consolidation of global medical information services is a multi-faceted endeavor with numerous challenges. Real-life examples of how multinational firms can manage the headwinds to develop flexible roadmaps for success can assist others in their journey.
Latest:
Effective patient-first approach in rare disease relies on true sales—not channel stockingHow the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings
Latest:
How the Rise of Personalized Medicine Impacts Life Sciences’ LogisticsAs this medical approach continues to become more widely adopted, the industry must adapt to help provide precise, compliant, temperature-controlled delivery of highly individualized treatments.
Latest:
Navigating Access and Reimbursement Through UncertaintyA forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.
Latest:
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient ServicesA guide to overcoming the top obstacles facing patient services programs today.
Latest:
The Prominence of Pharmacy DesertsHow chain and local closures are impacting healthcare access.
Latest:
FDA Offers 12-Month DSCSA Stabilization Period, but Urges Industry Not to DelayA breakdown on the decision, and how to navigate these obstacles using a network approach.
Latest:
Remaking the Trial Medication Adherence SpaceIQVIA informs us, new prescriptions for chronic therapies were 20% below what they were before 2020 and telemedicine patient encounters have settled at 10%. Accenture informs us, the low point of in-person pharma rep sales calls over the last year was 35%. These three facts point to lower access to trial medication and give strong impetus for remaking the trial medication adherence space. The CDC informs us that medication non-adherence causes up to 125,000 preventable deaths and $100 billion to 300 billion in preventable medical costs each year. Trial medication is a key solution to medication adherence. Pharmaceutical Commerce asked Hal Walsh, CEO of SymmetryRx, to tell us about the latest digital solutions that truly streamline the route from the manufacturer to the hands of patients in today’s high-tech, low-touch world.
Latest:
Getting to answers about Biogen’s AduhelmExploring RCT, RWE and alternative study designs as a path forward
Latest:
Obesity Drugs in the Payer Market: What to ExpectPayers won’t let these products break the bank.
Latest:
Empowering Patients in a Complex Healthcare SystemA deep dive into the future of patient service programs and the value of transparency throughout the process.
Latest:
Developing a Robust Serialization ProgramVarious considerations can help pharmaceutical manufacturers and suppliers provide a robust serialization solution based on the FDA's Drug Supply Chain Security Act.
Latest:
Herspiegel Consulting Dives Into the Value NarrativeKapil Raina, MD, Principal of Market Access at Herspiegel Consulting, talks about disconnects in the industry, how patients have easier access to healthcare information, and the exciting future of pharmaceutical manufacturing and patient care.
Latest:
Addressing Polypharmacy Challenges in Europe with Real World EvidenceA multi-national study reveals over half of older adults in several European countries are prescribed five or more medications—spotlighting the urgent need for better data-driven prescribing strategies.
Latest:
Keys to CGT-Supply Chain IntegrationOutlining five network-focused ways industry can support cold chain shipping of advanced therapy products
Latest:
The Future Heats Up Due to Cold ChainGains in temperature-controlled logistics, accelerated by the pandemic, have reshaped the landscape for global pharma distribution
Latest:
Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor PartnershipsThere are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.
Latest:
The march to DSCSA interoperabilityBarcode assessment project demonstrates the ground gained in meeting serialization-readiness requirements for supply chain transparency
Latest:
Strategic Insight and Forecasting: From Pipeline to PharmacyHow pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.
Latest:
Patient Hubs in an Omnichannel WorldHow personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes.
Latest:
Dealing with Dangerous GoodsThe packaging and shipping of dangerous goods (DG) adds further challenges to the distribution pressures brought about by the pandemic
Latest:
What Pharma Companies Need to Know About Entering the Great White NorthProduct commercialization in Canada is by no means simple, but the end result presents its advantages
Latest:
Building Agility and Adaptability Into Pharma OperationsWhy driving results from such strategies—amid industry disruption—will be critical to success.
Latest:
Counterfeit Meds: Fighting the ForgersQuestions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.
Latest:
Safeguarding Time and Temperature Sensitive PharmaWhen identifying a third-party service provider for ground transport of pharmaceutical freight, it is essential that the shipper partner with a company equipped with the expertise and technologies to plan for and monitor necessary shipments as well as respond to issues that may compromise the freight along its journey.
Latest:
Three criteria for choosing pharma containersThe top criteria to consider when evaluating and choosing the right airfreight container that can efficiently protect pharma’s cold chain
Latest:
The Synergies in Combining Artificial Intelligence and Market AccessAlthough AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?
Latest:
Marketing Data Hubs: When Operations and Analytics CollideHow to best plan out and implement a marketing data hub as a key tool to harnessing today’s omnichannel transformation in pharma
